| Documentation of Patient Outcomes for SSG/Allopurinol Combination Treatment in Ethiopia (NCT04699383) | Institute of Tropical Medicine, Belgium | 2021-02-15 |
| Miltefosine and GM-CSF in Cutaneous Leishmaniasis (NCT03023111) | Hospital Universitário Professor Edgard Santos | 2017-06-30 |
| Accuracy of a Rapid Diagnostic Test for Cutaneous Leishmaniasis in Morocco (NCT02979002) | National School of Public Health, Morocco | 2016-12-01 |
| Thermotherapy + a Short Course of Miltefosine for the Treatment of Uncomplicated Cutaneous Leishmaniasis in the New World¨ (NCT02687971) | Drugs for Neglected Diseases | 2016-12-01 |
| Prospective Observational Study of Intralesional Treatment With Pentostam in Cutaneous Leishmaniasis Israeli Patients (NCT02281669) | Sheba Medical Center | 2014-11-01 |
| Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia (NCT01845727) | Drugs for Neglected Diseases | 2014-02-01 |
| High Dose Fluconazole in Cutaneous Leishmaniasis in Bahia and Manaus (NCT01953744) | Hospital Universitário Professor Edgard Santos | 2014-02-01 |
| Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in Panama (NCT01790659) | U.S. Army Medical Research and Development Command | 2013-05-01 |
| WR 279,396 Open Label Treatment Protocol in Tunisia (NCT01494350) | U.S. Army Medical Research and Development Command | 2011-12-01 |
| Add-on Study of Pentoxifylline in Cutaneous Leishmaniasis (NCT01464242) | Centro Internacional de Entrenamiento e Investigaciones Médicas | 2011-11-01 |
| Pharmacokinetics of Miltefosine in Children and Adults (NCT01462500) | Centro Internacional de Entrenamiento e Investigaciones Médicas | 2011-10-01 |
| Efficacy of Topical Liposomal Form of Drugs in Cutaneous Leishmaniasis (NCT01050777) | Tehran University of Medical Sciences | 2011-03-01 |
| Intralesional Antimony for Bolivian Cutaneous Leishmaniasis (NCT01300975) | Fundacion Nacional de Dermatologia | 2011-01-01 |
| Miltefosine to Treat Mucocutaneous Leishmaniasis (NCT01050907) | Knight Therapeutics (USA) Inc | 2010-05-01 |
| A Study of the Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous Leishmaniasis (NCT01011309) | Access to Advanced Health Institute (AAHI) | 2009-10-01 |
| Frequency of Parasite Infection in Hyraxes and Sandflies During Outbreak of Leishmania Tropica Epidemic in The West Bank (NCT00737386) | Hadassah Medical Organization | 2009-09-01 |
| Study of the Efficacy of Daylight Activated Photodynamic Therapy in the Treatment of Cutaneous Leishmaniasis (NCT00840359) | Hadassah Medical Organization | 2009-09-01 |
| Efficacy of Radio-frequency Induced Heat (RFH)Therapy in Treatment of Cutaneous Leishmaniasis in India (NCT01661296) | Sarder Patel Medical College | 2009-08-01 |
| Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous Leishmaniasis (NCT01301924) | Oswaldo Cruz Foundation | 2008-10-01 |
| Safety, False-Positive Reactions and Sensitizing Properties of Leishmania Tropica Skin Test Antigen (NCT00633009) | Nielsen BioSciences, Inc. | 2008-08-01 |
| Safety and Efficacy of Azithromycin to Treat Cutaneous Leishmaniasis (NCT00682656) | Ana Rabello | 2008-06-01 |
| Oral Miltefosine Plus Topical Imiquimod to Treat Cutaneous Leishmaniasis (NCT01380314) | Foundation Fader | 2008-03-01 |
| Phase 3 Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia) (NCT00606580) | U.S. Army Medical Research and Development Command | 2008-01-01 |
| Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia (NCT00487253) | Centro Internacional de Entrenamiento e Investigaciones Médicas | 2007-07-01 |
| Efficacy of Intra-lesional Injections of Glucantime Once a Week or Twice a Week in the Treatment of Anthroponotic Cutaneous Leishmaniasis (ACL) (NCT04340128) | Tehran University of Medical Sciences | 2007-05-01 |
| Cosmetic Outcome of Leishmaniasis Scar After WR279396 Application (NCT00490230) | U.S. Army Medical Research and Development Command | 2007-04-01 |
| Treatment of Cutaneous Leishmaniasis With a Combination of Miltefosine and Antimony (NCT01380301) | Foundation Fader | 2007-03-01 |
| Topical Treatment of Recalcitrant Ulcerative Old World Leishmaniasis With WR 279,396 (NCT00657917) | U.S. Army Medical Research and Development Command | 2006-12-20 |
| Efficacy and Safety of Miltefosine or Thermotherapy for Cutaneous Leishmaniasis in Colombia. (NCT00471705) | Universidad de Antioquia | 2006-06-01 |
| Efficacy Trial on Oral Miltefosine in Comparison With Glucantime in the Treatment of ACL Caused by L. Tropica (NCT00351520) | Tehran University of Medical Sciences | 2006-05-01 |
| Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis (NCT00317629) | Fundación Cardiovascular de Colombia | 2006-05-01 |
| Surveillance for Leishmaniasis Skin Lesions in Mali (NCT00344084) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-16 |
| Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis (NCT00317980) | University of Brasilia | 2006-02-01 |
| Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis (NCT00257530) | Drugs for Neglected Diseases | 2005-12-01 |
| Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia (NCT00233545) | AB Foundation | 2005-09-01 |
| Study to Evaluate the Leish-111f + MPL-SE Vaccine in Healthy Adults Not Previously Exposed to Leishmania Parasite (NCT00121862) | Access to Advanced Health Institute (AAHI) | 2005-08-01 |
| Safety Study to Evaluate the Leish-111f + MPL-SE Vaccine in the Prevention of Cutaneous Leishmaniasis in Healthy Subjects Previously Exposed to the Leishmania Parasite (NCT00121849) | Access to Advanced Health Institute (AAHI) | 2005-08-01 |
| Local Heat Therapy Versus Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis (NCT00884377) | U.S. Army Medical Research and Development Command | 2004-02-01 |
| Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: A Phase 2 Study in the Old World (NCT00703924) | U.S. Army Medical Research and Development Command | 2003-03-01 |
| Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants (NCT00001906) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-04-01 |
| Pilot Study Using a Heat Pack to Treat Cutaneous Leishmaniasis (NCT01277796) | Universidad Peruana Cayetano Heredia | |